Board VC/PE backed Companies

Curated adds Kirsten Green to its Board along with launching thanks to $27.5 total funding

– USA, CA –  Curated, the platform that brings together people and products by matching customers with unbiased experts for high-consideration purchases, today announced its official launch with $27.5 million Series A funding round led by Forerunner Ventures, the firm behind Warby Parker, Glossier, Away, Faire and more.… => Read full post

MIRROR announces Steve Cohen to its Board along with raising $34m Series B-1 financing led by Point72 Ventures

– USA, NY –  MIRROR, the first nearly invisible, interactive home gym revolutionizing the in-home fitness experience, today announced it has secured $34 million in Series B-1 financing led by Point72 Ventures, and including lululemon (NASDAQ:LULU); supermodel, entrepreneur and philanthropist Karlie Kloss; Kevin Huvane, founder of Creative Artists Agency; Steve Lockshin, accomplished angel investor; seasoned media investors, LionTree LLC; as well as return investors, Spark Capital, and Lerer Hippeau.… => Read full post

Fountain adds David Chao to its Board along with raising $23m Series B funding round led by DCM Ventures

– USA, CA –  Fountain, the recruiting platform for gig and hourly workers, today announced the closing of a $23 million Series B funding round led by DCM, with participation from 51job and existing investors Origin Ventures, Uncork Capital, and others.… => Read full post

Green Rabbit adds Doug Kingsley and Won Park to Board along with securing $31m minority investment from Guidepost Growth Equity

– USA, MA –  Green Rabbit, the leading e-commerce cold chain logistics provider to the food industry, today announced that it has secured a $31 million minority investment from Guidepost Growth Equity, a leading growth equity firm focused on high-growth technology companies.… => Read full post

Disc Medicine announces Donald Nicholson to its Board along with raising $50m Series A financing led by Novo Holdings

– USA, MA –  Disc Medicine, a hematology company applying new insights in hepcidin biology to develop therapies that restore red blood cell production in hematologic diseases, today announced the completion of a $50 million Series A financing led by Novo Holdings A/S along with Access Biotechnology and founding investor Atlas Venture that seeded the company in 2017.… => Read full post